Advertisement

Clinical and Experimental Nephrology

, Volume 23, Issue 4, pp 573–575 | Cite as

Temporal change in life and renal prognosis of rapidly progressive glomerulonephritis in Japan via nationwide questionnaire survey

  • Kunihiro YamagataEmail author
  • Joichi Usui
  • Hitoshi Sugiyama
  • Shoichi Maruyama
  • Ichiei Narita
Letter to the editor
  • 119 Downloads

Keywords

Rapidly progressive glomerulonephritis ANCA-associated glomerulonephritis Prognosis Questionnaire survey 

Notes

Acknowledgements

We offer our thanks to the following members of RPGN Working Group of Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan: Dr. Shinya Kaname, Dr. Tatsuo Tsukumoto, Dr. Eri Muso, Dr. Kousaku Nitta, Dr. Takashi Wada, Dr. Yoshio Taguma, Dr. Masaki Kobayashi, Dr. Junichiro Nakata, Dr. Takashi Yokoo, Dr. Tetsuya Kawamura, Dr. Yukio Yuzawa, Dr. Kouichi Asahi, Dr. Hitoshi Nakashima, Dr. Shouichi Fujimoto, Dr. Shinji Hirawa, Dr. Tomo Suzuki, Dr. Wako Yumura, Dr. Takashi Ito, Dr. Kazuhiko Tsuruya, Dr. Masaharu Yoshida, Dr. Masayuki Iwano, Dr. Naotake Tsuboi, Dr. Ken-ei Sada, Dr. Yasunori Iwata, Dr. Ryohei Kaseda, Dr. Shuzo Kaneko, Dr. Seiichi Matsuo, Dr. Naoto Yamaguchi, and Dr. Akio Koyama. In addition, we also thank the nationwide investigators and institutions that participated in this survey. We also appreciate Ms. Yuko Sudo and Ms. Keiko Fujioka for their guidance in manuscript preparation. This work was supported by grants from Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan.

References

  1. 1.
    Arimura Y, et al. Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014. Clin Exp Nephrol. 2016;20(3):322–41.CrossRefGoogle Scholar
  2. 2.
    Koyama A, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13(6):633–50.CrossRefGoogle Scholar
  3. 3.
    Masakane I, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2013). Ther Apher Dial. 2015;19(6):540–74.CrossRefGoogle Scholar
  4. 4.
    Hilhorst M, et al. Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant. 2013;28(2):373–9.CrossRefGoogle Scholar
  5. 5.
    Sada KE, et al. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Arthritis Res Ther. 2015;17:305.CrossRefGoogle Scholar
  6. 6.
    Wakasugi M, Kazama JJ, Narita I. Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan. Ther Apher Dial. 2015;19(3):201–6.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2018

Authors and Affiliations

  1. 1.Department of Nephrology, Faculty of MedicineUniversity of TsukubaTsukubaJapan
  2. 2.Department of Human Resource Development of Dialysis Therapy for Kidney DiseaseOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesOkayamaJapan
  3. 3.Department of Nephrology, Internal MedicineNagoya University Graduate School of MedicineNagoyaJapan
  4. 4.Division of Clinical Nephrology and RheumatologyNiigata University Graduate School of Medical and Dental SciencesNiigataJapan

Personalised recommendations